Kinnari Patel, Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), bought 11,350 shares at $14.98 ($170K) on 2018-12-06, disclosed to the SEC on 2018-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.98 | 5,675 | $85K | 50.0% |
| 2 | $14.98 | 5,675 | $85K | 50.0% |
| Total | $14.98 avg | 11,350 | $170K | 100% |
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |